Literature DB >> 29168278

A role for intravenous immunoglobulin in the treatment of Acquired Von Willebrand Syndrome associated with IgM gammopathy.

M Lavin1,2, K Ryan1, B White1, M Byrne1, N M O'Connell1, J S O'Donnell1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29168278     DOI： 10.1111/hae.13374

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  4 in total

1.  Management of rare acquired bleeding disorders.

Authors:  Marzia Menegatti; Eugenia Biguzzi; Flora Peyvandi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Acquired von Willebrand syndrome and lymphoproliferative disorders: A case report.

Authors:  Christophe Nicol; Leela Raj; Gaëlle Guillerm; Francis Couturaud; Jean-Richard Eveillard; Brigitte Pan-Petesch
Journal:  Clin Case Rep       Date:  2020-03-09

Review 3.  Von Willebrand disease in the elderly: clinical perspectives.

Authors:  John Chapin
Journal:  Clin Interv Aging       Date:  2018-08-31       Impact factor: 4.458

4.  Distinct Mechanisms of IgM Antibody-Mediated Acquired von Willebrand Syndrome and Successful Treatment with Recombinant von Willebrand Factor in One Patient.

Authors:  Matthias Höpting; Ulrich Budde; Andreas Tiede; Matthias Grube; Joachim Hahn; Wolfgang Herr; Susanne Heimerl; Christina Hart
Journal:  Acta Haematol       Date:  2022-01-27       Impact factor: 3.068
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.